180: Alan Morton, Prostate Cancer Endurant - Newcastle Upon Tyne, United Kingdom
Release Date: 06/29/2026
Cancer Interviews
In 2024, Dominique Bieger knew something was wrong when she felt a tickling, biting sensation in her left breast. After a series of mammograms, an echogram, an ultrasound and a vacuum assisted biopsy, she learned she had invasive ductal carcinoma, or breast cancer. She would have to get a quadrant of the cancerous breast surgically removed. Dominique was happy to learn she could avoid chemotherapy, instead for hormonal treatment, featuring letrozole, an aromatase inhibitor. The letrozole left her hands, her feet and joints in severe pain. She went off the...
info_outlineCancer Interviews
For David Peters, what began as medical attention to address an enlarged prostate in 2022 became a diagnosis of Stage 4B prostate cancer. Prior to his undergoing a Rezum procedure, a pre-op workup a PSA level of 19. However, nobody at the hospital bothered to check the PSA level before performing the procedure, which placed David at great risk. Not long after that came his diagnosis. David’s care team recommended lifelong androgen deprivation therapy. He checked out the side effects and didn’t want to go that route. David instead opted for a three-week...
info_outlineCancer Interviews
In May 2022, Tina Calderone-Roth felt terrible. She was experiencing fatigue, shortness of breath and nausea. She also gained close to 15 pounds in three days. Nurses she knew suggested she go to the emergency department. Two paracentesis procedures resulted in the removal of 6.5 liters of fluid. Doctors initially noticed a large abdominal mass, but further tests indicated ovarian masses of 7cm and 10cm. Tests also showed Tina had the BRCA-2 gene mutation. She opted to, all at once, undergo a hysterectomy and bilateral oophorectomy. A week after the...
info_outlineCancer Interviews
Bethany Smith is a fighter. Almost immediately after surviving Hodgkin lymphoma, she was diagnosed with metastatic follicular thyroid cancer. In addition to having her thyroid removed, she also underwent total hip replacement. All this while raising three small children. Treatment of her lymphoma included a chemotherapy regimen of adriamycin, bleomycin, vinblastine and dacarbzin. Her treatment for thyroid cancer featured radioactive iodine. Bethany credits oxygen therapy for helping her to become free of thyroid cancer and these maintains her health with...
info_outlineCancer Interviews
It wasn’t easy, but Thomas Goode managed to survive Stage III multiple myeloma, a rare form of blood cancer that originates in bone marrow. When he first experienced pain in his left shoulder, it was misdiagnosed as bursitis. Then he underwent a stem cell transplant no less than three times, with his oldest brother donating the bone marrow for the final two procedures. Thomas has achieved Minimal Residual Disease status and says his physical health is roughly 70 percent of what it was, pre-diagnosis. In 2005, Thomas Goode was leading an active lifestyle. It...
info_outlineCancer Interviews
In March 2025, Keri Darling fell out of bed and hit her head. A trip to the doctor revealed a large mass on her pancreas. After a series of scans, Keri received a phone call at work from a nurse who told her she had cancer; not cancer of the pancreas, but a type of blood cancer, Stage IV follicular non-Hodgkin lymphoma. She was put on a regimen of chemotherapy, bendamustine, followed by immunotherapy, rituximab. Keri has achieved survivorship, but each day deals with severe fatigue, which she believes is tied to her chemo regimen. She still goes in for bimonthly...
info_outlineCancer Interviews
Alan Morton experienced symptoms associated with prostate cancer, but it was some time before he sought medical attention. Dating back to his teens, he had had a subpar urine flow, but in his sixties, he began to see blood in his urine. He thought it might be a urinary tract infection, but when nothing had changed six months later, he contacted his doctor. After various scans, a digital rectal exam and a biopsy, Alan was told he had Stage 3B prostate cancer. It was later determined the cancer had metastasized to his pelvic and was re-diagnosed as Stage 4...
info_outlineCancer Interviews
Shannon Miller won seven Olympic medals as a gymnast in 1992 and 1996. She did so against topflight competition, but years later, she faced a more formidable foe: a diagnosis of ovarian cancer. Her tumor was successfully removed through a procedure called a Unilatera Salpingo-Oophorectomy, but two weeks after that, she learned it more malignant than originally thought. Aided by the mental toughness she exhibited as an elite athlete, Shannon went on a grueling, nine-week regimen of BEP chemotherapy and reached survivorship. In 2011, Shannon experienced bloating,...
info_outlineCancer Interviews
Dale Atkinson Description In 2024, Dale Atkinson was diagnosed with Stage IV esophageal cancer. His diagnosis preceded by the death of his mother and was preceded by his partner being diagnosed with lung cancer. All this in the space of a few weeks. Dale was active in sports and consumed a healthy diet, but in 2019 began to suffer chronic acid reflux. His symptoms were repeatedly treated as acid reflux, but it wasn’t until 2024 that he underwent an endoscopy, which immediately revealed a tumor and a diagnosis of Stage IV esophageal cancer. ...
info_outlineCancer Interviews
Early in Dr, Jessa Landmann’s medical training, she discovered a need for attention given to those after they had received treatment for cancer. The post-treatment phase can be difficult physically, mentally and emotionally. Nutrition, what survivors eat, how much they eat and when they eat is where she starts in dealing with those going through the multi-layered challenges of post-treatment. Dr. Landmann urges those in the post-treatment phase to be proactive and seek direction from healthcare professionals. Dr. Landmann is by trade a naturopathic...
info_outlineAlan Morton experienced symptoms associated with prostate cancer, but it was some time before he sought medical attention. Dating back to his teens, he had had a subpar urine flow, but in his sixties, he began to see blood in his urine. He thought it might be a urinary tract infection, but when nothing had changed six months later, he contacted his doctor. After various scans, a digital rectal exam and a biopsy, Alan was told he had Stage 3B prostate cancer. It was later determined the cancer had metastasized to his pelvic and was re-diagnosed as Stage 4 Incurable. He was placed on a hormone regimen including the injection of a drug called decapeptyl. Alan said the side effects were awful, including fatigue, loss of muscle mass, weight gain and a severe loss of testosterone. He suspects he will be on the hormone regimen for the rest of his life, but Alan Morton calls himself a prostate cancer endurant. He still engages in hiking, and despite the handicaps, seeks to live life to the fullest.
It was in 2023 when Alan began to pass blood in his urine. He didn’t think this development was worth sharing with his wife or his doctor. However, his wife saw what she thought was dark urine when Alan went to the bathroom and forgot to flush. He told her he was passing blood and she immediately made a doctor’s appointment for him.
Alan submitted to a digital rectal exam and provided a urine sample. Although he thought the sample was “crystal clear,” the doctor said the sample included “microscopic blood.” He was called in for another appointment, provided another blood sample. From that and a biopsy, he received a diagnosis of Stage 3B prostate cancer.
Because of neck trauma stemming from a long ago auto accident, Alan could have his prostate removed. His care team concluded the only available treatment option would be a hormone regimen, starting with androgen deprivation therapy, or ADT. He said the effect it had on his body was awful. They included fatigue, severe loss of testosterone, hair loss, plus weight gain in various places, among them, his breasts. He was subsequently prescribed the injection of a drug, decapeptyl, and a pill called bucalutamide, designed to stop the growth of the tumor.
The ADT regimen stopped in October 2024, but the following month he began to pass blood again. To make matters worse, his PSA, once at 0.037, rose sharply to 6.39 in April 2026. Alan underwent a bone scan that indicated his cancer had spread to his pelvis. He is back on ADT and expects he will be for the rest of his life.
Alan says his urinary function is outstanding but would rate his sexual function at something like 20 to 30 percent of what it was pre-diagnosis.
Alan Morton does not call himself a survivor of cancer, but rather an endurant. He knows given his diagnosis and his hormone regimen, he is at reduced capacity, but aspires to live a full, rich life.
Additional Resources:
Support Group:
Fans for the Cure: https://www.fansforthecure.org